Drug archive
Tacrine (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Dementia symptoms treatment adjunct
Description
Tacrine (TAK-reen) is used to treat the symptoms of mild to moderate Alzheimer's disease. Tacrine will not cure Alzheimer's disease, and it will not stop the disease from getting worse. However, tacrine can improve thinking ability in some patients with Alzheimer's disease.
In Alzheimer's disease, many chemical changes take place in the brain. One of the earliest and biggest changes is that there is less of a chemical messenger called acetylcholine (ACh). ACh helps the brain to work properly. Tacrine slows the breakdown of ACh, so it can build up and have a greater effect. However, as Alzheimer's disease gets worse, there will be less and less ACh, so tacrine may not work as well.
Tacrine may cause liver problems. While taking this medicine, you must have blood tests regularly to see if the medicine is affecting your liver.
This medicine is available only with your doctor's prescription, in the following dosage form:
- Capsules (U.S.)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Cognex
Other commonly used names are THA and tetrahydroaminoacridine .
† Not commercially available in Canada.